glp-1 receptor agonist antipsychotic weight gain study How Agonists Evolved from Diabetes to Loss Treatments Metformin for the Prevention of
Description
Further randomized trials with larger sample sizes, including NAFLD patients with and without diabetes and incorporating active control groups, are needed to confirm these findings [45]
2025, pp
PMC 7386876
Int J Obes (2016) 40(8):13109
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population
